EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (Under Process) , 

 ISSN 2394-3211

Impact Factor: 4.897

 ICV - 79.57

Abstract

ASSESSMENT OF PRESCRIBING PATTERN OF BRONCHODILATORS FOR PATIENTS WITH RESPIRATORY TRACT INFECTION IN A TERTIARY CARE TEACHING HOSPITAL

Jacob N. Thomas*, Harshith A. S., Chandragiri Naveen Kumar Reddy and A. Vikneswari

ABSTRACT

Background: Respiratory disorder such as Asthma, Chronic Obstructive Pulmonary Disease (COPD), and RTI may account for an estimated burden of about 100 million individuals in India. There are limited data on the burden of respiratory disease in India. There is a growing appreciation of the benefits of bronchodilation beyond lung function, such as exacerbations, patient-reported outcomes, exercise tolerance and exercise capacity, and daily activities. Objectives: This was a prospective observational study with the aim of analysing the drug prescribing patterns of bronchodilators for patients with RTI in a tertiary care hospital. Methodology: The study has been conducted on male and female patients who were satisfying the inclusion criteria. A suitably designed case record form was prepared and used to record all the necessary and relevant data from the medical records of patients. Result: A total of 173 patients were analyzed in our study. In that, 22 were LRTI patients, 18 were Pneumonia patients, 7 were Post TB sequel with LRTI, 1 was Pneumonia with TB patient, 1 was LRTI with Pneumonia with COPD and 1 was TB with Asthma patient. Remaining cases belongs to other respiratory disorder. Out of 173 cases 8% were below 30 years, 16% were between 31 to 50 years, 59% were between 51 to 70 years and 17% were above 70 years old. Out of 173 cases, 126 were males and 47 were females. We divided 173 patients based on their smoking habit. 79 patients (46%) were found to be smokers, 55 patients (35%) were non-smokers and 33 patients (19%) were ex-smokers. The most used pattern of bronchodilator therapy is combination therapy of Anticholinergic + Beta 2 sympathomimetic + Methylxanthine (57.80%) followed by Anticholinergic + Beta 2 sympathomimetic (27.74%), Beta 2 sympathomimetics(10.40%) and Beta 2 sympathomimetic + Methylxanthine (4.04%). Most used (97.68%) route of bronchodilator therapy is nebulization (alone or with other routes) followed by intravenous, oral route of administration. Conclusion: Pulmonary disorders such as Asthma, COPD, LRTI etc. are prominent causes of death in the world. The majority of patients have intermittent exacerbations of RTI due to the inadequate pattern of drug use.

Keywords: Pulmonary disorder, RTI, Bronchodilator.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 October 2018 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR OCTOBER ISSUE PUBLISHED

    OCTOBER 2018 Issue has been successfully launched on 1 October 2018

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from 4.161 to 4.897 due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (Under Process)